Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.60 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.40 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.39 |
| ▸ | ALB | P02768 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CCKAR | P32238 | 1/20 | 0.36 |
| ▸ | CCKBR | P32239 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12424086 | 0.99 | GLP1R (0.62) | GLP1RNOD1C3AR1FOLH1ALB | |
| SCHEMBL22627100 | 0.92 | GLP1R (0.58) | GLP1RC3AR1FOLH1ALB | |
| SCHEMBL16478790 | 0.91 | GLP1R (0.57) | GLP1RNOD1C3AR1FOLH1ALB | |
| SCHEMBL19261649 | 0.90 | GLP1R (0.58) | GLP1RNOD1C3AR1FOLH1ALB | |
| SCHEMBL17401159 | 0.88 | GLP1R (0.64) | GLP1RNOD1C3AR1FOLH1CCKAR | |
| SCHEMBL21172198 | 0.88 | GLP1R (0.61) | GLP1RNOD1C3AR1FOLH1 | |
| SCHEMBL21172401 | 0.88 | GLP1R (0.47) | GLP1RFOLH1 | |
| SCHEMBL21172251 | 0.87 | GLP1R (0.62) | GLP1RNOD1C3AR1FOLH1EPHX2 | |
| SCHEMBL19069582 | 0.87 | GLP1R (0.56) | GLP1RC3AR1FOLH1ALB | |
| SCHEMBL21172359 | 0.87 | GLP1R (0.49) | GLP1RFOLH1CCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2981282-B1 | GROWTH HORMONE COMPOUND FORMULATION | NOVO NORDISK HEALTHCARE AG (CH) | 2020-11-04 | — | — | EP | disclosed |
| EP-2525834-B1 | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY | NOVO NORDISK HEALTHCARE AG (CH) | 2019-07-17 | — | — | EP | disclosed |
| WO-2011089255-A1 | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY | NOVO NORDISK HEALTH CARE AG (CH) | 2011-07-28 | — | — | WO | disclosed |